Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 3027-3035, November 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hittelman, W. N.
Right arrow Articles by Rao, P. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hittelman, W. N.
Right arrow Articles by Rao, P. N.

The Nature of Adriamycin-induced Cytotoxicity in Chinese Hamster Cells as Revealed by Premature Chromosome Condensation1

Walter N. Hittelman and Potu N. Rao

Department of Developmental Therapeutics, The University of Texas at Houston, M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77025

The short- and long-term effects of adriamycin treatment on the cell cycle kinetics and chromosome structure of Chinese hamster ovary cells were investigated. Adriamycin treatment, either pulse or continuous, did not delay the progression of G1 cells into S phase but did prolong the duration of S and G2 phases. This effect was dose dependent, and the prolongation of G2 period was greater than that of S. The frequency of chromosomal aberrations induced by adriamycin was studied in the mitotic as well as in the prematurely condensed chromosomes (PCC) of the treated cells. The types of aberrations observed were chromosome stickiness, chromatid exchanges, breaks, and gaps. The frequency of aberrations continued to increase as cells progressed to mitosis even after the removal of drug from the medium. At prolonged intervals (24 to 72 hr) after a brief or extended treatment, the labeling indices of the treated populations decreased, indicating an eventual block in the cell cycle progression. Visualization of chromosomes of these blocked interphase cells by the PCC method revealed that normal G2 PCC were totally absent. We observed that the PCC of these blocked cells were abnormal in the following respects: (a) some of the G2 PCC were extensively damaged; (b) many of the S PCC failed to incorporate [3H]thymidine; (c) a significant fraction of these PCC were poorly condensed and hence it was difficult to determine whether they were in G1 or G2. These results indicate that there is a good correlation between damage to the genome and the inhibition of cell cycle progression after adriamycin treatment.

1 This investigation was supported in part by Grants CA-16480 and CA-14528-02 and Contract NO1-CM-61156 from the National Cancer Institute, NIH, USPHS, and Grant VC-163 from the American Cancer Society.

Received 4/14/75. Accepted 7/25/75.




This article has been cited by other articles:


Home page
ScienceHome page
T. Weinert and L. Hartwell
The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae
Science, July 15, 1988; 241(4863): 317 - 322.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.